These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10078910)

  • 21. AD2000: donepezil in Alzheimer's disease.
    Schneider LS
    Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of electroacupuncture combined with donepezil on cognitive function in Alzheimer's disease patients: study protocol for a randomized controlled trial.
    Peng W; Zhou J; Xu M; Feng Q; Bin L; Liu Z
    Trials; 2017 Jul; 18(1):301. PubMed ID: 28673322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
    Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
    J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression.
    Inoue J; Hoshino R; Nojima H; Ishida W; Okamoto N
    Psychogeriatrics; 2016 Jan; 16(1):54-61. PubMed ID: 25919986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
    Vollmar HC; Butzlaff M
    Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence-based psychopharmacology 1. Appraising a single therapeutic trial: what is the evidence for treating early Alzheimer's disease with donepezil?
    Warner JP
    J Psychopharmacol; 1999; 13(3):308-12. PubMed ID: 10512093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donepezil-responsive alcohol-related prolonged delirium.
    Hori K; Tominaga I; Inada T; Oda T; Hirai S; Hori I; Onaya M; Teramoto H
    Psychiatry Clin Neurosci; 2003 Dec; 57(6):603-4. PubMed ID: 14629709
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficacy, efficiency and evidence -- studies on donepezil].
    Wallesch CW; Ebert AD
    Fortschr Neurol Psychiatr; 2004 Oct; 72(10):555-6. PubMed ID: 15472778
    [No Abstract]   [Full Text] [Related]  

  • 29. Donepezil in advanced dementia, or delirium?
    Palmer TR
    J Am Med Dir Assoc; 2004; 5(1):67. PubMed ID: 14726803
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug-induced lupus erythematosus associated with donepezil: a case report.
    Manzo C; Putignano S
    Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease.
    Seripa D; Bizzarro A; Pilotto A; D'onofrio G; Vecchione G; Gallo AP; Cascavilla L; Paris F; Grandone E; Mecocci P; Santini SA; Masullo C; Pilotto A
    Pharmacogenet Genomics; 2011 Apr; 21(4):225-30. PubMed ID: 20859244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donepezil use for advanced Alzheimer's disease--a case study from a long-term care facility.
    Tariot PN; Jakimovich L
    J Am Med Dir Assoc; 2003; 4(4):216-9. PubMed ID: 12837144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease.
    Waldemar G; Gauthier S; Jones R; Wilkinson D; Cummings J; Lopez O; Zhang R; Xu Y; Sun Y; Knox S; Richardson S; Mackell J
    Int J Geriatr Psychiatry; 2011 Feb; 26(2):150-7. PubMed ID: 20597141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing therapeutic efficacy in a progressive disease: a study of donepezil in Alzheimer's disease.
    Johannsen P; Salmon E; Hampel H; Xu Y; Richardson S; Qvitzau S; Schindler R;
    CNS Drugs; 2006; 20(4):311-25. PubMed ID: 16599649
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donepezil for Alzheimer's disease.
    Benjamin B; Burns A
    Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donepezil update.
    Drug Ther Bull; 1998 Aug; 36(8):60-1. PubMed ID: 9876403
    [No Abstract]   [Full Text] [Related]  

  • 37. Comprehensive approach of donepezil and psychosocial interventions on cognitive function and quality of life for Alzheimer's disease: the Osaki-Tajiri Project.
    Meguro M; Kasai M; Akanuma K; Ishii H; Yamaguchi S; Meguro K
    Age Ageing; 2008 Jul; 37(4):469-73. PubMed ID: 18515851
    [No Abstract]   [Full Text] [Related]  

  • 38. Urinary incontinence: an unrecognised adverse effect with donepezil.
    Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
    Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
    van Hout HP; Bosmans JE; Stalman WA
    Neurology; 2005 Apr; 64(7):1320; author reply 1320. PubMed ID: 15824386
    [No Abstract]   [Full Text] [Related]  

  • 40. Donepezil therapy for neuropsychiatric symptoms in AD: methods make the message.
    Herrmann N; Knopman D
    Neurology; 2004 Jul; 63(2):200-1. PubMed ID: 15277606
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.